Merck & Co., Inc.
$148.23
+7.30 · +5.18% today
Market open · updated 12:44:26 PM ET
- High
- $142.16 10:50 AM
- Low
- $140.20 12:25 PM
Against the S&P 500 Price change through Oct 27, 2026
MRK+34.73%
S&P 500+12.87%
MRK+61.16%
S&P 500+12.32%
MRK+37.93%
S&P 500+87.41%
MRK+73.93%
S&P 500+69.55%
Key numbers
- Previous close
- $140.93
- Open
- $144.62
- Day's range
- $143.63 – $149.24
- 52-week range
- $82.01 – $156.92
- Volume
- 4.8 million
- Average volume
- 10.3 million
- Market value
- $365.7 billion
- Price to earnings
- 111.6last 12 months
- Earnings per share
- $1.28last 12 months
- Beta
- 0.22moves less than the market
- Dividend
- $3.40 a year · 2.42%
- 50-day average
- $146.97
- 200-day average
- $126.32
Thursday, Oct 29, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Merck competes with From our value chain
Merck in the news
No desk stories on MRK yet. When we write about it, the story leads this list.
- HeadlineBrokers Suggest Investing in Merck (MRK): Read This Before Placing a BetZacks Investment Research · October 28, 2026 at 10:31 AM ET
- HeadlineIs Merck Stock a Buy, Sell or Hold Ahead of Q3 Earnings?Zacks Investment Research · October 27, 2026 at 10:01 AM ET
- HeadlineMerck Highlights Phase III Cancer Wins, Eyes 2027 Oncology Pipeline CatalystsMarketBeat · October 26, 2026 at 8:04 PM ET
- HeadlineMerck & Co., Inc. (MRK) Shareholder/Analyst Call TranscriptSeeking Alpha · October 26, 2026 at 6:09 PM ET
- HeadlineCountdown to Merck (MRK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research · October 26, 2026 at 10:16 AM ET
- HeadlineBeyond Keytruda: The Critical Pipeline Metrics to Watch in Merck's Q3 Results on Oct. 2924/7 Wall Street · October 25, 2026 at 11:31 AM ET
- HeadlineMerck (MRK) Laps the Stock Market: Here's WhyZacks Investment Research · October 21, 2026 at 6:46 PM ET
- HeadlineMerck (MRK) Stock Dips While Market Gains: Key FactsZacks Investment Research · October 19, 2026 at 6:51 PM ET
Earnings
Next report: Thursday, Oct 29, 2026, before the open.
Congress trades in MRK
3 purchases and 5 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Michael McCaulHouse · R-Texas | Sale | $50,001 - $100,000 | Aug 28, 2026 | Oct 16, 2026 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Purchase | $15,001 - $50,000 | Aug 7, 2026 | Sep 7, 2026 |
| Keith SelfHouse · R-Texas | Sale | $1,001 - $15,000 | Jan 10, 2025 | Jul 1, 2026 |
| Josh GottheimerHouse · D-New Jersey | Purchase | $1,001 - $15,000 | Feb 4, 2026 | Mar 17, 2026 |
| Michael McCaulHouse · R-Texas | Sale | $15,001 - $50,000 | Jan 13, 2026 | Feb 12, 2026 |
| Julie JohnsonHouse · D-Texas | Sale | $1,001 - $15,000 | Dec 18, 2025 | Jan 16, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Dec 19, 2025 | Jan 13, 2026 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Merck
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 74,000
- Headquarters
- Rahway, New Jersey
- Website
- merck.com
- Listed
- Jan 13, 1978
More drug manufacturers - general stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.